Dexcom

Support type: Corporate Pump and Device Supporters

Level: Gold

Founded in 1999, Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering our community to take control of diabetes.
For more information on Dexcom G6 visit https://uk.provider.dexcom.com/

Privacy Policy | Website Terms and Conditions

Address for correspondence: ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602 Email: info@abcd.care

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd

ABCD Corporate Pharma Sponsors; Gold: Astra Zeneca, Lilly, Sanofi. Silver: A.Menarini Farmaceutica Internazionale SRL,

ABCD Corporate Pump & Device Supporters, Gold: Abbott Laboratories Ltd, Dexcom, GlucoRx, Insulet International Ltd, Ypsomed Ltd; Silver: Air Liquide Healthcare Ltd, Medtrum Ltd, Menarini Diagnostics; Bronze: Roche Diabetes Care.

Read the ABCD statement on pharmaceutical industry funding

Search form

You are here

Dexcom

ABCD Webinar Series